Presence of Tissue Transglutaminase IgA Antibody as a Celiac Disease Marker in a Sample of Patients with Irritable Bowel Syndrome
Vol. 34 No. 1 (2015), Brief Report
Vol. 34 No. 1 (2015)

Presence of Tissue Transglutaminase IgA Antibody as a Celiac Disease Marker in a Sample of Patients with Irritable Bowel Syndrome

Brief Report
Published 2015-02-20
Alberto L. Zamot
University of Puerto Rico Medical Science Campus Internal Medicine Department Gastroenterology Division
Esther A. Torres
Henry González
Manuel A. Marcial
PDF

Keywords

• Celiac Disease
Irritable Bowel Syndrome
tissue transglutaminase IgA antibody
Puerto Rico

How to Cite

Zamot, A. L., Torres, E. A., González, H., & Marcial, M. A. (2015). Presence of Tissue Transglutaminase IgA Antibody as a Celiac Disease Marker in a Sample of Patients with Irritable Bowel Syndrome. Puerto Rico Health Sciences Journal, 34(1). Retrieved from https://prhsj.rcm.upr.edu/index.php/prhsj/article/view/901
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Recent medical literature agrees that celiac disease (CD) is much more prevalent in western civilization than it was thought to be in the past. Given the potential complications and consequences of untreated CD, screening programs have been considered. Symptoms of celiac disease may resemble those of Irritable Bowel Syndrome. A group of patients with IBS was screened for CE using the Tissue Transglutaminase Antibody IgA serum test. A total of 18 patients were screened. All of our patients tested negative for TT G IgA. This finding may indicate that the prevalence of CD may be low in our population. Further population studies are needed to confirm our finding.
PDF
Authors who publish with this journal agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).